This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
CLINICAL CASE
Large hepatocellular adenoma of the liver in a woman of reproductive age
1 Rostov State Medical University, Rostov-on-Don, Russia
2 Gorky Donetsk State Medical University, Donetsk, Russia
3 Razumovsky Saratov State Medical University, Saratov, Russia
Correspondence should be addressed: Anastasia O. Ivanenko
Alma-Atinskaya, 24, Rostov-on-Don, 344009, Russia; ur.liam@10.ayisatsana.oknenavi
Author contribution: Chichelnitsky AK, Savchenko DA — manuscript writing and editing; Zhuk ER, Buimova ES — literature review, data analysis, manuscript writing; Kostina AS, Raklov DA — literature review, data acquisition, manuscript writing; Negodaeva AI, Ivanenko AO — concept and design, literature review, manuscript writing; Aduchieva VI — literature review, manuscript writing and editing.
Compliance with ethical standards: the patient submitted the informed consent for publication of anonymized personal medical information.
Hepatocellular adenoma is a rare benign liver tumor with the potentially unfavorable course due to the risk of hemorrhage and malignant transformation. Treatment depends on the mass subtype and size. Here we present a clinical case of hepatocellular adenoma in a woman of reproductive age developed against the background of the long-term use of oral contraceptives. The tumor sized 8 cm was detected accidentally during instrumental examination; morphological and immunohistochemistry assessment confirmed that it was a benign one without β-catenin mutation. Liver resection was performed. The case highlights the importance of careful monitoring of the patients during the long-term use of oral contraceptives, as well as of the timely surgical interventions in individuals with large hepatocellular adenomas to prevent hemorrhage and malignization.
Keywords: hepatocellular adenoma, liver tumors, estrogen-containing drugs, liver resection